The first institutional-grade operating system for the life settlement market
"The LiqueFex DNA System is to the life settlement market what the CUSIP is to the public securities market — a foundational identification and data standard that makes institutional-scale trading possible."
The LiqueFex DNA System provides a unique identification standard for every life settlement asset — the CUSIP equivalent this market has never had. It creates a real-time data schema and living data history for every policy, accumulating structured information across the full lifecycle of each asset. All downstream OS functions — valuation, compliance, settlement, clearing — draw directly from the DNA System, making it the foundational layer on which the entire OS is built.
LiqueFex OS enables same-day settlement through custodian-bank-accepted trade instruments linked directly to the DNA System. These vehicles bring life settlement transactions into the settlement infrastructure institutional participants already use — eliminating the manual, fragmented settlement processes that have historically excluded institutional capital from this market.
Compliance in LiqueFex OS is embedded at the protocol level — not overlaid as a post-process. Every transaction and asset interaction is governed by compliance logic built into the architecture, creating a complete and immutable audit trail. Compliance cannot be bypassed because it is not a layer on top of the OS — it is a structural property of the OS itself.
LiqueFex OS replaces central counterparty clearing with a peer-to-peer settlement architecture that scales horizontally. Without a central clearinghouse dependency, settlement velocity and capacity scale with market participation rather than being constrained by centralised infrastructure. This architecture is purpose-built for the volume characteristics of an institutionally-scaled life settlement market.
Artificial intelligence and blockchain are both embedded at the infrastructure level of LiqueFex OS — not retrofitted to existing processes. AI functions operate across valuation, risk modelling, and data enrichment. Blockchain provides the immutable record layer across the OS. Both are cross-platform by design, enabling integration with institutional systems already operating in these environments.
LiqueFex DNA System — the live data layer
Every life settlement policy assigned a DNA System identifier accumulates a structured, real-time data history — medical, actuarial, custodial, and transactional records attached to a single, permanent reference.
The DNA System is to the life settlement market what the CUSIP is to the public securities market — a foundational identification and data standard that makes institutional-scale trading possible. All downstream OS functions — valuation, compliance, settlement, clearing — draw directly from this layer.
What the OS delivers
Unique, persistent reference for every life settlement policy across all participants.
Live data schema enabling systematic, institutional-grade mark-to-market.
Compliance at protocol level — structural, not overlaid. Full audit trail by default.
Custodian-bank-accepted instruments enabling settlement at institutional velocity.
Peer-to-peer settlement architecture that scales horizontally with market volume.
Both embedded at infrastructure level — not retrofitted. Cross-platform by design.
A five-step operating sequence
Every policy enters the OS through the DNA System, receiving a unique, persistent identifier — the foundational reference for all downstream operations.
Medical, actuarial, custodial, and transactional data streams attach to the DNA record in real time, building a living data history for the asset.
Protocol-level compliance logic governs every interaction — creating an immutable audit trail without manual oversight or post-process verification.
Custodian-bank-accepted settlement instruments are issued, linking directly to the DNA record and enabling same-day institutional settlement.
Peer-to-peer clearing replaces central counterparty dependency, scaling settlement capacity horizontally with market participation.